Dr. Michael A. Childs, MD

Dr. Childs practices at Arkansas Urology, P.A. in Little Rock, Arkansas.

Dr. Childs' NPI, 1568669448, was assigned on July 2, 2007. Dr. Childs graduated from McGovern Medical School in 2007. Dr. Childs' Arkansas license number on file is E-7454.

Dr. Childs' primary practice is Arkansas Urology, P.A., at 1300 Centerview Dr, Little Rock, AR 72211 in Pulaski County. The practice phone is (501) 219-8900.

Dr. Childs' primary practice is Arkansas Urology, P.A. in Little Rock, Arkansas. Dr. Childs is also affiliated with Mercy Hospital Northwest Arkansas. The medical group on file is Arkansas Urology. Dmand AI also links Dr. Childs to 2 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Childs practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Childs' primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Childs is board certified in urology by the American Board of Urology. Dmand AI has Dr. Childs' licenses on file in 2 states: Arkansas and Minnesota.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and pelvic prolapse among the conditions Dr. Childs treats.

CMS data shows 5,068 Medicare services from Dr. Childs across 34 procedure codes in 2024, for 437 Medicare patients. Medicare paid $192,037 for them.

CMS counts 437 Medicare patients who saw Dr. Childs in 2024. The largest group is 65 to 74, with 230 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Childs' median patient age at 69, with 16% women.

In 2024, Dr. Childs wrote 1,579 Medicare Part D claims for 465 patients. 83% of them were for generic drugs. CMS names the drug for 1,427 of them, across 27 drugs with 11 or more claims each, at $973,520 in total drug cost. In 2023, CMS named 1,455 claims across 27 drugs.

Dr. Childs accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Childs as offering telehealth. CMS counts 11 procedures of prostate resection by Dr. Childs, more than 60% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Childs, published from 2010 to 2012. The most frequent topics are Kidney Neoplasms, Carcinoma, Renal Cell and Neoplasms, Second Primary. Dr. Childs has published most often in BJU Int. Dr. Childs' most frequent co-authors are Eric C. Umbreit, MD, Matthew T. Gettman, MD and Bradley C. Leibovich, MD.

CMS Open Payments shows 367 general payments to Dr. Childs from 47 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 89% of the total. Boston Scientific Corporation paid the most, $1,205.

Dmand AI lists 1 award for Dr. Childs, most recently CMS Stage 1 EHR in 2013.

Dr. Childs graduated from McGovern Medical School in 2007. Dr. Childs is a member of AOA, AMA and AUA.

Dr. Childs is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.